Patents Represented by Attorney, Agent or Law Firm Barbara Rae-Venter
  • Patent number: 5278066
    Abstract: Novel microbial host strains are provided which are transformed by a vector molecule comprising a DNA fragment encoding a lipolytic enzyme and a marker for selection, capable of producing active lipase. Said DNA fragment is preferably derived from a Pseudomonas species.
    Type: Grant
    Filed: September 25, 1989
    Date of Patent: January 11, 1994
    Assignee: Gist-brocades NV
    Inventors: Peter M. Andreoli, Maria M. J. Cox, Farrokh Farin
  • Patent number: 5238833
    Abstract: Novel methods and novel industrial unicellular microorganism strains, particularly industrial Bacillus strains, are provided for enhanced production of endogenous and exogenous polypeptides. Cloning vehicles containing the gene expressing the polypeptide of interest are introduced into a compatible host. Transformed hosts harboring the introduced vehicle in a stable way by integration of the vehicle into the host cells chromosome are selected Efficient transfer of the vehicle containing the gene of interest is achieved, with the resulting industrial strain transformants being effective, stable producers of the desired polypeptide product.
    Type: Grant
    Filed: May 13, 1991
    Date of Patent: August 24, 1993
    Assignee: Gist-brocades, NV
    Inventors: Johan P. M. Sanders, Johannes A. Van Den Berg, Peter M. Andreoli, Yvonne J. Vos, Jan H. Van EE, Leo J. S. M. Mulleners
  • Patent number: 5217878
    Abstract: Novel methods and novel industrial Bacillus strains are provided for enhanced production of serine protease. Plasmid constructs comprising the serine protease gene are introduced into a compatible host, generally a Bacillus already overproducing serine protease. Preferred host cells are those from Bacillus novo sp. PB92 and the preferred serine protease gene also originates from Bacillus PB92. Integration and maintenance of the plasmid in the host cell chromosome can be achieved by including a temperature sensitive origin of replication in the plasmid construct and growing under selective conditions.
    Type: Grant
    Filed: February 29, 1988
    Date of Patent: June 8, 1993
    Assignee: Gist-Brocades, NV
    Inventors: Christiaan A. G. van Eekelen, Johannes C. van der Laan, Leo J. S. M. Mulleners
  • Patent number: 5217891
    Abstract: DNA constructs that are useful for providing secretory expression of heterologous polypeptides in yeast comprising a DNA sequence that includes a Kluyveromyces .alpha.-factor leader sequence linked to the heterologous polypeptide by a yeast processing signal. Constructs employing the K. lactis .alpha.-factor leader and processing signal sequences, with and without spacer, linked to prochymosin are exemplified.
    Type: Grant
    Filed: April 9, 1990
    Date of Patent: June 8, 1993
    Assignees: Chiron Corporation, Gist-Brocades
    Inventors: Anthony J. Brake, Johan A. Van Den Berg
  • Patent number: 5212070
    Abstract: Novel vectors are provided for identifying secretory signal sequences from DNA fragments of unicellular microorganisms. The plasmids comprise a multiple cloning site with restriction sites in reading frame with a structural gene which permits rapid screening of the secreted expression product. Optionally, the vectors may include a promoter region upstream from the multiple cloning site. The invention is exemplified with Bacillus. Specific secretory signal sequences have been isolated with those vectors, allowing for efficient secretion into the supernatant, and not just to the periplasmic space to provide proteins in economically high yields. Secretory sequences are provided superior to other previously known sequences.
    Type: Grant
    Filed: December 13, 1990
    Date of Patent: May 18, 1993
    Assignee: Gist-brocades
    Inventors: Hilde E. Smith, Jan H. Van Ee, Ben P. H. Peeters, Sierd Bron, Gerard Venema
  • Patent number: 5202247
    Abstract: A fusion protein is prepared containing a polypeptide such as an enzyme and an amino acid sequence having a substrate binding region of a polysaccharidase such as cellulase that has essentially no polysaccharidase activity. By contacting the fusion protein with an affinity matrix containing a substrate such as cellulose for the cellulase substrate binding region, the substrate binding region binds to the affinity matrix to immobilize the polypeptide. The polypeptide can be purified by separating the fusion protein or polypeptide from the affinity matrix. The polypeptide can be separated by cleaving the protein with a Cellulomonas fimi protease.
    Type: Grant
    Filed: October 25, 1990
    Date of Patent: April 13, 1993
    Assignee: University of British Columbia
    Inventors: Douglas G. Kilburn, Robert C. Miller, Richard A. J. Warren, Neil R. Gilkes
  • Patent number: 5202252
    Abstract: Compositions and methods for their use are provided for preventing proliferation of remnant lens epithelial cells following extracapsular extraction. Complement-fixing monoclonal antibodies specific for lens epithelial cells are introduced into the anterior chamber of the eye. Following binding of the monoclonal antibody to any lens epithelial cells, complement is introduced into the anterior chamber effecting lysis of the remnant lens epithelial cells. The method may be used at the time of extracapsular cataract extraction or may be used subsequently to remove a second cataract resulting from proliferation of remnant lens epithelial cells.
    Type: Grant
    Filed: June 14, 1988
    Date of Patent: April 13, 1993
    Assignee: Houston Biotechnology Inc.
    Inventors: Jared M. Emery, Dominic M. Lam, Peter J. Kelleher
  • Patent number: 5198599
    Abstract: Plants, plant tissues and plant seeds which are resistant to inhibition by sulfonylurea and/or imidazolinone herbicides are provided. In particular, domestic lettuce varieties having resistance to herbicides which target the enzyme acetolactate synthase are provided. The resistant plants find use in areas where weed growth is controlled by sulfonylurea and/or imidazolinone herbicides.
    Type: Grant
    Filed: June 5, 1990
    Date of Patent: March 30, 1993
    Assignee: Idaho Resarch Foundation, Inc.
    Inventor: Donald C. Thill
  • Patent number: 5196525
    Abstract: Novel transcription initiation regions that provide for enhanced transcription of a DNA sequence, particularly a plant sequence, are provided.
    Type: Grant
    Filed: April 8, 1991
    Date of Patent: March 23, 1993
    Assignee: University of British Columbia
    Inventors: Joan C. McPherson, Robert Kay
  • Patent number: 5190877
    Abstract: Methods and compositions are provided relating to yeasts capable of improved fermentation of sugars. Particularly, genes from the MAL locus are used for transformation of yeast hosts, where the genes are under the wild-type promoter or a strong promoter which provides for regulatable or constitive expression under the conditions of fermentation. Particularly, the yeast hosts find use in the leavening of dough.
    Type: Grant
    Filed: November 13, 1990
    Date of Patent: March 2, 1993
    Assignee: Gist-brocades N.V.
    Inventors: Klaas A. Osinga, Robert F. Beudeker, Johannes B. Van der Platt, Johannes A. de Hollander
  • Patent number: 5177307
    Abstract: Developmentally regulated transcriptional regulatory regions are identified employing cDNA screening. The resulting regulatory regions are manipulated for use with DNA sequences encoding enzymes involved in cytokinin metabolism for introduction into plant cells to provide transformed plants having tissue, particularly fruit, with a modified phenotypic property.
    Type: Grant
    Filed: July 17, 1990
    Date of Patent: January 5, 1993
    Assignee: Calgene, Inc.
    Inventors: Catherine M. Houck, Julie R. Pear, Belinda M. Martineau, William Hiatt
  • Patent number: 5175095
    Abstract: Novel DNA constructs are provided which may be used as molecular probes or inserted into a plant host to provide for modification of transcription of a DNA sequence of interest in ovary tissue, particularly in very early fruit development. The DNA constructs comprise a transcriptional initiation regulatory region associated with gene expression in ovary tissue from immediately prior to anthesis through flower senescence.
    Type: Grant
    Filed: July 17, 1990
    Date of Patent: December 29, 1992
    Assignee: Calgene, Inc.
    Inventors: Belinda M. Martineau, Catherine M. Houck
  • Patent number: 5173402
    Abstract: DNA sequences of hCMV are obtained by restriction of the hCMV genome, the resulting fragments free of fragments cross-hybridizing with human DNA and other viruses may be used for hybridization with clinical samples suspected of containing hCMV to provide a sensitive method for detection of hCMV at low particle number.
    Type: Grant
    Filed: August 2, 1988
    Date of Patent: December 22, 1992
    Assignee: The Regents of the University of California
    Inventors: Deborah H. Spector, Stephen A. Spector
  • Patent number: 5171844
    Abstract: Novel polypeptides having Factor VIII activity are provided as well as compositions and methods for their preparation. The polypeptides comprise derivatives and fragments of Factor VIII and have sequences substantially similar to portions of naturally occuring Factor VIII. The polypeptides find use in treatment of Hemophilia A.
    Type: Grant
    Filed: June 10, 1988
    Date of Patent: December 15, 1992
    Assignee: Gist-Brocades N.W.
    Inventors: Albert J. J. van Ooyen, Hans Pannekoek, Martinus P. Verbeet, Robert W. van Leen
  • Patent number: 5168048
    Abstract: The invention provides a gene encoding penicillin G acylase, the enzyme encoded by said gene and a method for the production of said enzyme by incorporating said gene in a host and bringing the same to expression. The gene is preferably obtained from a strain of the microorganism Alcaligenes faecalis.
    Type: Grant
    Filed: April 18, 1991
    Date of Patent: December 1, 1992
    Assignee: Gist-brocades NV
    Inventor: Wilhelmus J. Quax
  • Patent number: 5164316
    Abstract: Novel transcription initiation regions that provide for enhanced transcription of a DNA sequence, particularly a plant sequence, are provided.
    Type: Grant
    Filed: August 17, 1989
    Date of Patent: November 17, 1992
    Assignee: The University of British Columbia
    Inventors: Joan C. McPherson, Robert Kay
  • Patent number: 5137819
    Abstract: A fusion protein is prepared containing a polypeptide such as an enzyme and an amino acid sequence having a substrate binding region of a polysaccharidase such as cellulase that has essentially no polysaccharidase activity. By contacting the fusion protein with an affinity matrix containing a substrate such as cellulose for the cellulase substrate binding region, the substrate binding region binds to the affinity matrix to immobilize the polypeptide. The polypeptide can be purified by separating the fusion protein or polypeptide from the affinity matrix.
    Type: Grant
    Filed: July 8, 1988
    Date of Patent: August 11, 1992
    Assignee: University of British Columbia
    Inventors: Douglas G. Kilburn, Robert C. Miller, Richard A. J. Warren, Neil R. Gilkes
  • Patent number: 5118607
    Abstract: Novel specific protein binding assays are provided employing a solvent system comprising a solvent characterized as hydrophobic, essentially anhydrous and water immiscible. Particularly, lipophilic analytes are shown to be sensitively determined using antibodies in hydrocarbon media, optionally substantially saturated with aqueous buffer and/or comprising an anionic surfactant.
    Type: Grant
    Filed: October 31, 1990
    Date of Patent: June 2, 1992
    Assignee: Hawaii Biotechnology Group, Inc.
    Inventors: Gary S. Bignami, Paul G. Grothaus
  • Patent number: 5107065
    Abstract: Regulation of expression of genes encoded for in plant cell genomes is achieved by integration of a gene under the transcriptional control of a promoter which is functional in the host and in which the transcribed strand of DNA is complementary to the strand of DNA that is transcribed from the endogenous gene(s) one wishes to regulate. The integrated gene, referred to as anti-sense, provides an RNA sequence capable of binding to naturally existing RNAs, exemplified by polygalacturonase, and inhibiting their expression, where the anti-sense sequence may bind to the coding, non-coding, or both, portions of the RNA. The antisense construction may be introduced into the plant cells in a variety of ways and be integrated into the plant genome for inducible or constitutive transcription of the anti-sense sequence. A wide variety of plant cell properties may be modifed by employing this technique.The pCGN978xK12 was deposited at the A.T.C.C. on Mar. 25, 1986, and given Accession No.
    Type: Grant
    Filed: August 30, 1988
    Date of Patent: April 21, 1992
    Assignee: Calgene, Inc.
    Inventors: Christine K. Shewmaker, Jean C. Kridl, William R. Hiatt, Vic Knauf
  • Patent number: 5094945
    Abstract: Enhanced resistance to glyphosate, an inhibitor of the aromatic amino acid biosynthesis pathway, is imparted to a glyphosate sensitive host. A mutated aroA gene is employed which expresses 5-enolpyruvyl-3-phosphoshikimate synthase (EC: 2.5.1.19) (ES-3-P synthase). Methods are provided for obtaining the aroA mutation which provides the enzyme resistant to inhibition by glyphosate, means for introducing the structural gene into a sensitive host, as well as providing a method of producing the enzyme.The E. coli strain C600 (pPMG1) has been deposited at the A.T.C.C. on December 14, 1982 and given A.T.C.C. Accession No. 39256.
    Type: Grant
    Filed: August 30, 1988
    Date of Patent: March 10, 1992
    Assignee: Calgene, Inc.
    Inventor: Luca Comai